187 related articles for article (PubMed ID: 34569094)
1. Complement Activation Is a Prominent Feature of MOGAD.
Keller CW; Lopez JA; Wendel EM; Ramanathan S; Gross CC; Klotz L; Reindl M; Dale RC; Wiendl H; Rostásy K; Brilot F; Lünemann JD
Ann Neurol; 2021 Dec; 90(6):976-982. PubMed ID: 34569094
[TBL] [Abstract][Full Text] [Related]
2. C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache F; Ringelstein M; Aktas O; Kleiter I; Jarius S; Siebert N; Bellmann-Strobl J; Paul F; Ruprecht K
J Neuroimmunol; 2021 Nov; 360():577699. PubMed ID: 34464830
[TBL] [Abstract][Full Text] [Related]
3. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
Front Immunol; 2021; 12():647618. PubMed ID: 33796113
[No Abstract] [Full Text] [Related]
4. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
[TBL] [Abstract][Full Text] [Related]
5. Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD).
Kwon YN; Kim B; Ahn S; Seo J; Kim SB; Yoon SS; Sung JJ; Choi YS; Kim SM
J Neuroimmunol; 2020 Nov; 348():577361. PubMed ID: 32919144
[TBL] [Abstract][Full Text] [Related]
6. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody.
Höftberger R; Guo Y; Flanagan EP; Lopez-Chiriboga AS; Endmayr V; Hochmeister S; Joldic D; Pittock SJ; Tillema JM; Gorman M; Lassmann H; Lucchinetti CF
Acta Neuropathol; 2020 May; 139(5):875-892. PubMed ID: 32048003
[TBL] [Abstract][Full Text] [Related]
7. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
[TBL] [Abstract][Full Text] [Related]
8. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
10. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.
Horellou P; de Chalus A; Giorgi L; Leroy C; Chrétien P; Hacein-Bey-Abina S; Bourgeois C; Mariette X; Serguera C; Le Grand R; Deiva K
Front Immunol; 2021; 12():679770. PubMed ID: 34220827
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F;
Acta Neuropathol Commun; 2019 Sep; 7(1):145. PubMed ID: 31481127
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Fujihara K; Cook LJ
Curr Opin Neurol; 2020 Jun; 33(3):300-308. PubMed ID: 32374571
[TBL] [Abstract][Full Text] [Related]
14. Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier R; Hacohen Y; Cobo-Calvo A; Pröbstel AK; Aktas O; Alexopoulos H; Amato MP; Asgari N; Banwell B; Bennett J; Brilot F; Capobianco M; Chitnis T; Ciccarelli O; Deiva K; De Sèze J; Fujihara K; Jacob A; Kim HJ; Kleiter I; Lassmann H; Leite MI; Linington C; Meinl E; Palace J; Paul F; Petzold A; Pittock S; Reindl M; Sato DK; Selmaj K; Siva A; Stankoff B; Tintore M; Traboulsee A; Waters P; Waubant E; Weinshenker B; Derfuss T; Vukusic S; Hemmer B
Lancet Neurol; 2021 Sep; 20(9):762-772. PubMed ID: 34418402
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?
Zheng Y; Cai MT; Li EC; Fang W; Shen CH; Zhang YX
Front Immunol; 2021; 12():671425. PubMed ID: 34220818
[TBL] [Abstract][Full Text] [Related]
16. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
[TBL] [Abstract][Full Text] [Related]
17. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Di Pauli F; Berger T
Front Immunol; 2018; 9():2753. PubMed ID: 30555462
[TBL] [Abstract][Full Text] [Related]
18. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
[TBL] [Abstract][Full Text] [Related]
19. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
20. Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort.
Sun X; Qiu W; Wang J; Wang S; Wang Y; Zhong X; Liu C; Cui C; Hong H; Yang H; Li XJ; Lu Z; Hu X; Kermode AG; Peng L
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):733-739. PubMed ID: 32430437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
